Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
ibandronate sodium
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Single-Dose Local Radiotherapy Versus Ibandronate in Patients With Localized Metastatic Bone Pain
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
CRUK-NCRI-RT-02-01
, EU-20224, RIB, ISRCTN86185157, NCT00082927
2.
Phase III Randomized Study of Adjuvant Zoledronate Versus Clodronate Versus Ibandronate in Women With Resected Primary Stage I-III Adenocarcinoma of the Breast
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-S0307
, NCCTG-SWOG-S0307, ECOG-SWOG-S0307, NSABP-SWOG-S0307, CALGB-SWOG-S0307, CAN-NCIC-SWOG-S0307, S0307, NCT00127205
3.
Study in Elderly Patients With Early Breast Cancer (ICE)
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Active
Age:
65 and over
Sponsor:
Other
Protocol IDs:
GBG32
, BIG 4-04, NCT00196859
4.
A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-Positive Primary Breast Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 64
Sponsor:
Other
Protocol IDs:
GBG 33
, GAIN, NCT00196872
5.
Phase III Randomized Study of Ibandronate Versus Zoledronate in Patients With Newly Diagnosed Bone Metastases Secondary to Breast Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
WCTU-ZICE
, NCRI-ZICE, ROCHE-ZICE, ISRCTN13914201, EU-20613, EUDRACT-2005-001710-40, NCT00326820
6.
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients
Phase:
Phase III
Type:
Supportive care
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
2006-0960
, NCT00824993
7.
Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients
Phase:
Phase II
Type:
Supportive care
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
ML20115
, EudraCT: 2006-000697-74, NCT00381368
8.
Study of Long-Term Bone Quality in Women With Primary Breast Cancer Enrolled on Clinical Trial SWOG-S0307
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Diagnostic, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
SWOG-S0307A
, S0307A, NCT00873808
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute